Assignee
BIORCHESTRA CO LTD
KR·5 granted patents·21 pending applications·9 citations·filing 2019–2023
Top patents by PatentIndex Score
26 records- 0187US10844380B1Uses for prevention or treatment of brain diseases using micrornaBIORCHESTRA CO LTD·Filed 2019·Granted Nov 24, 2020·6 cites·19 claims
- 0284US11198908B2Method for diagnosis of Alzheimer's disease using microRNABIORCHESTRA CO LTD·Filed 2019·Granted Dec 14, 2021·3 cites·19 claims
- 0372US2023340477A1Uses for prevention or treatment of brain diseases using micrornaBIORCHESTRA CO LTD·Filed 2023·Application pending·0 cites
- 0469US2024173348A1Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2023·Application pending·0 cites
- 0567US12084718B2Method for diagnosis of Alzheimer's disease using micrornaBIORCHESTRA CO LTD·Filed 2021·Granted Sep 10, 2024·0 cites·19 claims
- 0664US11839624B2Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2021·Granted Dec 12, 2023·0 cites·23 claims
- 0764US11542503B2Uses for prevention or treatment of brain diseases using microRNABIORCHESTRA CO LTD·Filed 2020·Granted Jan 3, 2023·0 cites·19 claims
- 0860US2025313835A1Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2023·Application pending·0 cites
- 0957US2024216529A1Extracellular vesicles with targeting moietyBIORCHESTRA CO LTD·Filed 2022·Application pending·0 cites
- 1054US2022257790A1Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2020·Application pending·0 cites
- 1153US2024117350A1Use of mirna-485 inhibitor to regulate psd95, synaptophysin, and caspase-3 expressionBIORCHESTRA CO LTD·Filed 2022·Application pending·0 cites
- 1252US2023220007A1Setd7 epigenetic modulatorsBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 1352US2024209035A1Polynucleotides capable of enhanced protein expression and uses thereofBIORCHESTRA CO LTD·Filed 2022·Application pending·0 cites
- 1451US2024294908A1Use of mirna-485 inhibitors for treating diseases or disorders associated with abnormal nlrp3 expressionBIORCHESTRA CO LTD·Filed 2022·Application pending·0 cites
- 1549US2024091151A1Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 1649US2023167502A1Diagnostic methods using mir-485-3p expressionBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 1749US2023099372A1Use of mirna-485 inhibitors for treating tauopathyBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 1849US2023304014A1Mirna-485 inhibitor for huntington's diseaseBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 1949US2024131048A1Micellar nanoparticles and uses thereofBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 2048US2022081690A1Use of mir-204 inhibitor to increase nurr1 protein expressionBIORCHESTRA CO LTD·Filed 2020·Application pending·0 cites
- 2147US2023256119A1Compositions and methods for preparing an alzheimer's disease animal model using micrornaBIORCHESTRA CO LTD·Filed 2020·Application pending·0 cites
- 2247US2024050461A1Use of mirna-485 inhibitors for inducing hair growthBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 2346US2023119699A1Diagnostic methods using sirt1 expressionBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 2444US2023121720A1Diagnostic methods using pcg-1a expressionBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 2542US2023126157A1Mirna-485 inhibitor for gene upregulationBIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
- 2642US2023131083A1Use of mirna-485 inhibitors for treating amyotrophic lateral sclerosis (als)BIORCHESTRA CO LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →